Granisetron sustained-release implant - Development Center for BiotechnologyAlternative Names: Longtril
Latest Information Update: 18 May 2016
At a glance
- Originator Development Center for Biotechnology
- Class Analgesics; Antiemetics; Azabicyclo compounds; Indazoles; Small molecules
- Mechanism of Action Serotonin 3 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Chemotherapy-induced nausea and vomiting